SERUM CD95 OF RELAPSING-REMITTING MULTIPLE-SCLEROSIS PATIENTS PROTECTS FROM CD95-MEDIATED APOPTOSIS

Citation
F. Zipp et al., SERUM CD95 OF RELAPSING-REMITTING MULTIPLE-SCLEROSIS PATIENTS PROTECTS FROM CD95-MEDIATED APOPTOSIS, Journal of neuroimmunology, 86(2), 1998, pp. 151-154
Citations number
30
Categorie Soggetti
Neurosciences,Immunology
Journal title
ISSN journal
01655728
Volume
86
Issue
2
Year of publication
1998
Pages
151 - 154
Database
ISI
SICI code
0165-5728(1998)86:2<151:SCORMP>2.0.ZU;2-#
Abstract
Failure of CD95-mediated apoptosis as a potential negative regulatory mechanism of T cell expansion may be involved in T cell-mediated autoi mmune diseases such as multiple sclerosis (MS). Recently, soluble CD95 has been shown to be elevated in MS patients with active disease. Her e, we report that the sera of MS patients inhibit CD95 ligand-induced apoptosis of susceptible target cells in a concentration-dependent man ner and dependent on the amount of serum CD95 levels. Thus, MS sera co ntain biologically active inhibitors of T cell apoptosis that may allo w for prolonged abnormal immune responses. (C) 1998 Elsevier Science B .V. All rights reserved.